#Enlil #Nader Fathi #Shifamed

Enlil's New CEO: Nader Fathi Set to Steering the Company Towards Greatness

CAMPBELL, California – Enlil, Inc., a key player in the Shifamed portfolio, recently made headlines with its appointment of Nader Fathi as Chief Executive Officer. This strategic selection underscores the company's commitment to accelerating innovation within the regulated product development sector. With a robust background in the high-tech and medical device industries, Fathi brings over three decades of experience in driving business growth, forming key partnerships, and spearheading digital transformation.

Against the backdrop of a flourishing MedTech ecosystem, which includes Original Equipment Manufacturers (OEMs), incubators, contract manufacturers, and regulatory consultants, Fathi's leadership arrives at a pivotal time. The new CEO is poised to leverage his extensive knowledge of advanced technologies, including Artificial Intelligence (AI), Business Intelligence (BI), manufacturing, and Internet of Things (IoT) cloud solutions, to enhance Enlil’s innovative capabilities and further its global outreach.

As reflected by the strong momentum Enlil has gained, the appointment indicates a readiness to elevate its status in regulated product development technology. Fathi's history of securing seven technology patents and successfully launching technology firms adds to the optimism surrounding his new role.

Vision for the Future

Fathi's focus includes expanding Enlil's investor network, accelerating sales efforts, and solidifying its market presence. Amr Salahieh, the founder of Shifamed and chairman of Enlil, emphasized the importance of Fathi's commitment to long-term funding and establishing strategic partnerships aimed at broader initial public offerings of Enlil's solutions.